Figitumumab (Anti-IGF1R / CD221)Figitumumab (Anti-IGF1R / CD221)
Move your mouse over image or click to enlarge

Figitumumab (Anti-IGF1R / CD221)

Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.
Cat# Size Price Qty Buy
A2942-1mg*25 1mg*25
£2,432.00
A2942-1mg*5 1mg*5
£794.00
A2942-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2942

Related Documents